Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Nehad M Alajez
Affiliation
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
ORCID
Career Start Year
2004
Papers
108
H Index
32
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36749553
iPSC-Derived Pancreatic Progenitors Lacking FOXA2 Reveal Alterations in miRNA Expression Targeting Key Pancreatic Genes.
Stem Cell Rev Rep
2023
37670346
Genome-wide differential expression profiling of long non-coding RNAs in FOXA2 knockout iPSC-derived pancreatic cells.
Cell Commun Signal
2023
37908488
High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder.
Front Mol Neurosci
2023
37511368
Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells.
Int J Mol Sci
2023
37770979
Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
Cell Commun Signal
2023
37727755
Long non-coding RNA AC099850.4 correlates with advanced disease state and predicts worse prognosis in triple-negative breast cancer.
Front Med (Lausanne)
2023
37190091
Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes.
Cells
2023
37175824
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia.
Int J Mol Sci
2023
37108604
Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study.
Int J Mol Sci
2023
37438342
Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks.
Cell Death Dis
2023
37400525
Author Correction: Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation.
Sci Rep
2023
35328807
Identification of Novel Circulating miRNAs in Patients with Acute Ischemic Stroke.
Int J Mol Sci
2022
35643221
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches.
Semin Cancer Biol
2022
36613546
Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients.
Int J Mol Sci
2022
36277770
Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus.
Front Cardiovasc Med
2022
36142814
Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation.
Int J Mol Sci
2022
35893227
LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities.
Noncoding RNA
2022
36354097
Reciprocal interplays between MicroRNAs and pluripotency transcription factors in dictating stemness features in human cancers.
Semin Cancer Biol
2022
32727251
Transcriptomic Profiling of Circulating HLA-DR<sup>-</sup> Myeloid Cells, Compared with HLA-DR<sup>+</sup> Myeloid Antigen-presenting Cells.
Immunol Invest
2021
33898797
Identification of PBMC-based molecular signature associational with COVID-19 disease severity.
Heliyon
2021
33863870
COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
Signal Transduct Target Ther
2021
33665229
Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel.
Mol Ther Methods Clin Dev
2021
33495450
Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy.
Cell Death Discov
2021
34959629
Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression.
Pharmaceuticals (Basel)
2021
34703883
Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq.
Mol Ther Oncolytics
2021
34565361
Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition.
Cancer Cell Int
2021
34771513
Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer.
Cancers (Basel)
2021
34326372
Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
Sci Rep
2021
34262080
Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer.
Sci Rep
2021
31271889
SOX4: Epigenetic regulation and role in tumorigenesis.
Semin Cancer Biol
2020
31801817
Pembrolizumab Interferes with the Differentiation of Human FOXP3<sup>+</sup>-Induced T Regulatory Cells, but Not with FOXP3 Stability, through Activation of mTOR.
J Immunol
2020
31978617
Resveratrol inhibits adipocyte differentiation and cellular senescence of human bone marrow stromal stem cells.
Bone
2020
31941522
Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Clin Epigenetics
2020
31733291
Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
Semin Cancer Biol
2020
33312958
RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis.
Front Oncol
2020
33138195
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
Cells
2020
32882823
Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2.
Biology (Basel)
2020
32646047
Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Genes (Basel)
2020
32984004
Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients.
Front Oncol
2020
32922961
MicroRNA-3148 acts as molecular switch promoting malignant transformation and adipocytic differentiation of immortalized human bone marrow stromal cells via direct targeting of the SMAD2/TGFβ pathway.
Cell Death Discov
2020
32393769
Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
Cell Death Dis
2020
32509578
MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
Front Oncol
2020
30993013
CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors.
Cell Death Discov
2019
31871467
Hedgehog Signaling Inhibition by Smoothened Antagonist BMS-833923 Reduces Osteoblast Differentiation and Ectopic Bone Formation of Human Skeletal (Mesenchymal) Stem Cells.
Stem Cells Int
2019
31835892
Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients.
Cancers (Basel)
2019
31767956
Author Correction: Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation.
Sci Rep
2019
31349612
PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer.
Cancers (Basel)
2019
31263577
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling.
Cell Death Discov
2019
31548560
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Sci Rep
2019
31620367
Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer.
Front Oncol
2019
1 - 50 of 108
Column Actions
Search
Recommended Authors
Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year
2015
Number of shared co-authors
1
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year
2012
Number of shared co-authors
0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year
2010
Number of shared co-authors
2
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year
2010
Number of shared co-authors
0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year
2008
Number of shared co-authors
0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
0
Joshy George
Peter MacCallum Cancer Centre
Career Start Year
2005
Number of shared co-authors
1
Antonio Sorrentino
Leibniz Institute for Immunotherapy (LIT)
Career Start Year
2005
Number of shared co-authors
0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year
2004
Number of shared co-authors
0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
0
Bin Yan
The University of Hong Kong
Career Start Year
2003
Number of shared co-authors
0
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
0
Emiliano Dalla
University of Udine
Career Start Year
2002
Number of shared co-authors
0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year
2001
Number of shared co-authors
0
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year
2001
Number of shared co-authors
0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year
2001
Number of shared co-authors
0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year
2000
Number of shared co-authors
0
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year
2000
Number of shared co-authors
1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
0
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year
1988
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers
22
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Co-authored papers
16
Angela B Y Hui
Stanford University
Co-authored papers
11
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers
9
Carlo Bastianutto
University of Toronto
Co-authored papers
6
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers
5
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Jian-Hua Li
th Hospital
Co-authored papers
2
Nico van Rooijen
Co-authored papers
2
John C Bell
Ottawa Hospital Research Institute
Co-authored papers
2
Robert G Bristow
University of Toronto
Co-authored papers
2
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers
2
Bayardo Perez-Ordonez
University Health Network
Co-authored papers
1
David R McCready
University of Toronto, University Health Network
Co-authored papers
1
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers
1
Christine How
Ontario Cancer Institute, University Health Network (UHN)
Co-authored papers
1
Peter P Liu
Co-authored papers
1
Kate Gerster
Ontario Cancer Institute
Co-authored papers
1
Rui Yan
University of Groningen, University Medical Center Groningen
Co-authored papers
1
Levi Waldron
City University of New York School of Public Health
Co-authored papers
1
Paul C Boutros
University of California los angeles
Co-authored papers
1
Daniel Durocher
The Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital
Co-authored papers
1
Tanvir Alam
College of Science and Engineering, Hamad Bin Khalifa University
Co-authored papers
1
Blaise A Clarke
University of Toronto.
Co-authored papers
1
Jeffrey A Medin
Medical College of Wisconsin
Co-authored papers
1
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers
1
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers
1
1 - 30